Acamprosate should only be initiated following advice from the drug and alcohol team, or other specialist. |
AMBER Acamprosate tablets e/c 333mg |
|
Nalmefene NICE TAG325 |
To be supplied via a locally commissioned specialist service in conjunction with continuos psychosocial support. |
RED Nalmefene tablets f/c 18mg |
|
Disulfiram is used as an adjunct in the treatment of alcohol dependence (under specialist supervision) |
AMBER Disulfiram tablets 200mg |
|
Chlordiazepoxide is used in treatment of alcohol withdrawal by Specialist Service only |
RED Chlordiazepoxide capsules 5mg, 10mg |
|
Back to Main Chapter |
|
Nicotine Replacement Therapy (NRT) |
NRT should not be prescribed by GPs. |
|
Individuals wishing to stop smoking should be referred to a local stop smoking service: |
Smoke Free Lancashire Service [excludes Blackburn with Darwen & Blackpool] |
Tel: 0808 1962 638 |
Email: smokefree.lancs@cgl.org.uk |
Referrals: click here |
|
Patients can self-refer directly to a stop smoking service provider <click here> For Blackburn with Darwen contact Blackburn with Darwen Stop Smoking Service. Blackburn with Darwen Re-Fresh Service Tel: Well Being Hub : 01254 682037 E: quitsmoking@blackburn.gov.uk Details of Community Pharmacies in Blackburn with Darwen providing Stop Smoking Services Click here |
|
Click here to access the Position Statement on GP Prescribing of NRT |
RED Nicotine replacement therapy |
|
Bupropion |
Bupropion (Zyban®) is contra-indicated in patients with a history of seizures or of eating disorders, or who are experiencing acute |
withdrawal from alcohol or benzodiazepines. Refer to prescribing information for full contra-indications and interactions. Use in |
line with NICE guidance. |
GREEN Bupropion tablets m/r 150mg |
|
Varenicline Please note: Varenicline (Champix®) 0.5mg and 1mg tablets are unavailable until further notice - see position statement |
Varenicline should only be prescribed on the direct advice of a smoking cessation adviser. |
|
> Patients presenting to their GP requesting varenicline should be referred to a smoking cessation adviser to help the |
patient choose the most appropriate smoking cessation product. This may not be varenicline. |
> Varenicline should be used where the use of nicotine replacement therapy (NRT) is not tolerated, ineffective or |
inappropriate. Varenicline has not been compared with NRT, although it has been shown to be superior to bupropion |
(Zyban®). |
> Smoking cessation, with or without pharmacotherapy, has been associated with the exacerbation of underlying |
psychiatric illness (e.g. depression). Care should be taken with patients with a history of psychiatric illness and patients |
should be advised accordingly. |
> There is no clinical experience with varenicline in patients with epilepsy. Patients should be advised of this, and explicit |
consent should be obtained if they wish to receive varenicline. |
> Varenicline should only be used within its licensed indications, and prescribed for smokers who commit to a target stop |
date and who smoke >10 cigarettes (or equivalent) per day. |
> The smoker should be offered regular follow up and advice to aid smoking cessation at least 2 weekly intervals |
|